Copiah County Medical Center | |
21790 Highway 28, Hazlehurst, Mississippi 39083 | |
(601) 574-7000 | |
Not Available |
Name | Copiah County Medical Center |
---|---|
Type | Critical Access Hospital |
Location | 21790 Highway 28, Hazlehurst, Mississippi |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 251327 |
NPI Number | 1083039663 |
Organization Name | COPIAH COUNTY MEDICAL CENTER |
Address | 27190 Highway 28, Hazlehurst, MS 39083 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 601-574-7000 |
News Archive
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
DARA BioSciences, Inc. announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for treatment of neuropathic pain in patients with cancer. Statistically significant primary endpoint results were released earlier.
VeriTeQ Acquisition Corporation, a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications, announced today it has acquired the VeriChip implantable microchip and related technologies, and Health Link personal health record from PositiveID Corporation.
A raft of lawsuits filed Thursday against St. Jude Medical Inc. over an implanted heart device could challenge the broad liability protection that medical-device makers have enjoyed since a key Supreme Court ruling in 2008.
› Verified 6 days ago
NPI Number | 1588667281 |
Organization Name | COPIAH COUNTY MEDICAL CENTER |
Address | 27190 Highway 28, Hazlehurst, MS 39083 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-574-7000 |
News Archive
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
DARA BioSciences, Inc. announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for treatment of neuropathic pain in patients with cancer. Statistically significant primary endpoint results were released earlier.
VeriTeQ Acquisition Corporation, a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications, announced today it has acquired the VeriChip implantable microchip and related technologies, and Health Link personal health record from PositiveID Corporation.
A raft of lawsuits filed Thursday against St. Jude Medical Inc. over an implanted heart device could challenge the broad liability protection that medical-device makers have enjoyed since a key Supreme Court ruling in 2008.
› Verified 6 days ago
NPI Number | 1972826121 |
Organization Name | COPIAH COUNTY MEDICAL CENTER |
Address | 27190 Highway 28, Hazlehurst, MS 39083 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 601-574-7000 |
News Archive
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
DARA BioSciences, Inc. announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for treatment of neuropathic pain in patients with cancer. Statistically significant primary endpoint results were released earlier.
VeriTeQ Acquisition Corporation, a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications, announced today it has acquired the VeriChip implantable microchip and related technologies, and Health Link personal health record from PositiveID Corporation.
A raft of lawsuits filed Thursday against St. Jude Medical Inc. over an implanted heart device could challenge the broad liability protection that medical-device makers have enjoyed since a key Supreme Court ruling in 2008.
› Verified 6 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
DARA BioSciences, Inc. announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for treatment of neuropathic pain in patients with cancer. Statistically significant primary endpoint results were released earlier.
VeriTeQ Acquisition Corporation, a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications, announced today it has acquired the VeriChip implantable microchip and related technologies, and Health Link personal health record from PositiveID Corporation.
A raft of lawsuits filed Thursday against St. Jude Medical Inc. over an implanted heart device could challenge the broad liability protection that medical-device makers have enjoyed since a key Supreme Court ruling in 2008.
› Verified 6 days ago
Copiah County Medical Center Critical Access Hospital Location: 21790 Highway 28, Hazlehurst, Mississippi 39083 Phone: (601) 574-7000 |